Device
Single Photon Emission Computed Tomography (SPECT)
Single Photon Emission Computed Tomography (SPECT) is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Terminated1
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
terminated133%
completed133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard
NCT06255769
terminatedphase_2
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
NCT04511026
completednot_applicable
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
NCT00608920
Clinical Trials (3)
Showing 3 of 3 trials
NCT06255769
Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard
NCT04511026Phase 2
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
NCT00608920Not Applicable
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3